Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term testosterone replacement in testicular cancer survivors
2015-004430-96Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Hypoandrogenism (TD) comparing Androgel with Placebo (2 arms). Primary endpoint: Change in fat mass percentage at 20 weeks. Started Aug 2017; status: completed.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2015-004430-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004430-96.